PIK3CA-related overgrowth spectrum: animal model and drug discovery

被引：5
|
作者：
Venot, Quitterie [1 ,2 ]
Canaud, Guillaume [1 ,2 ,3 ,4 ]
机构：
[1] Inst Necker Enfants Malad, INSERM, U1151, Paris, France
[2] Univ Paris, Paris, France
[3] Hop Necker Enfants Malad, AP HP, Unite Hypercroissance Dysharmonieuse, Paris, France
[4] Hop Necker Enfants Malad, AP HR, Serv Nephrol Transplantat Adultes, Paris, France
来源：
COMPTES RENDUS BIOLOGIES | 2021年 / 344卷 / 02期
关键词：
PIK3CA; Animal model; Clinical trial; PIK3CA-related overgrowth spectrum; Mosaicism; PIK3CA(H1047R) MUTATION; DIAGNOSIS; PIK3CA; EXPRESSION;
D O I：
10.5802/crbiol.50
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
This review recapitulates the recent knowledge accumulation on overgrowth syndrome related to gain of function of the phosphoinositide3 kinase (PI3K)-alpha. These disorders, known as PIK3CA related overgrowth syndromes (PROS) are caused by somatic PIK3CA mutation occurring during embryogenesis. We summarize here the currently available animal models and new treatments undergoing development.
引用
收藏
页码：189 / 201
页数：13
相关论文
共 50 条
  • [41] Immune cell infiltration and drug sensitivity in PIK3CA-mutated esophageal squamous cell carcinoma: A TCGA database analysis
    He, Shuo
    Liu, Qing
    Luo, Shujuan
    Cai, Bangwu
    Chen, Jiao
    Peng, Tianyuan
    Wang, Wei
    Liu, Tao
    Lu, Xiaomei
    Zheng, Shutao
    HUMAN IMMUNOLOGY, 2024, 85 (06)
  • [42] Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast
    An, Yeji
    Adams, Jessica R.
    Hollern, Daniel P.
    Zhao, Anthony
    Chang, Stephen G.
    Gams, Miki S.
    Chung, Philip E. D.
    He, Xiaping
    Jangra, Rhea
    Shah, Juhi S.
    Yang, Joanna
    Beck, Lauren A.
    Raghuram, Nandini
    Kozma, Katelyn J.
    Loch, Amanda J.
    Wang, Wei
    Fan, Cheng
    Done, Susan J.
    Zacksenhaus, Eldad
    Guidos, Cynthia J.
    Perou, Charles M.
    Egan, Sean E.
    CELL REPORTS, 2018, 25 (03): : 702 - +
  • [43] Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer
    Yip, Hon Yan Kelvin
    Shin, Sung-Young
    Chee, Annabel
    Ang, Ching-Seng
    Rossello, Fernando J.
    Wong, Lee Hwa
    Nguyen, Lan K.
    Papa, Antonella
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [44] Establishment of a Novel In Vitro Model of Endometriosis with Oncogenic KRAS and PIK3CA Mutations for Understanding the Underlying Biology and Molecular Pathogenesis
    Hossain, Mohammad Mahmud
    Nakayama, Kentaro
    Shanta, Kamrunnahar
    Razia, Sultana
    Ishikawa, Masako
    Ishibashi, Tomoka
    Yamashita, Hitomi
    Sato, Seiya
    Iida, Kouji
    Kanno, Kosuke
    Ishikawa, Noriyoshi
    Kiyono, Tohru
    Kyo, Satoru
    CANCERS, 2021, 13 (13)
  • [45] Clinicopathological and Molecular Insights into Primary Retroperitoneal Squamous Cell Carcinoma: HPV Association and Discovery of Recurrent PIK3CA E545K Mutation
    Kim, Han gyeol
    Moon, Sung kyoung
    Kim, Hyun-soo
    Na, Kiyong
    ANTICANCER RESEARCH, 2025, 45 (02) : 719 - 731
  • [46] A Novel Preclinical In Vitro 3D Model of Oral Carcinogenesis for Biomarker Discovery and Drug Testing
    Suryaprakash, Ravi Teja Chitturi
    Shearston, Kate
    Farah, Camile S.
    Fox, Simon A.
    Iqbal, Muhammad Munir
    Kadolsky, Ulrich
    Zhong, Xiao
    Saxena, Alka
    Kujan, Omar
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [47] 3D pulmonary fibrosis model for anti-fibrotic drug discovery by inkjet-bioprinting
    Kang, Dayoon
    Lee, Yunji
    Kim, Wookyeom
    Lee, Hwa-Rim
    Jung, Sungjune
    BIOMEDICAL MATERIALS, 2023, 18 (01)
  • [48] Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors
    Baldassari, Federica
    Zerbinati, Carlotta
    Galasso, Marco
    Corra, Fabio
    Minotti, Linda
    Agnoletto, Chiara
    Previati, Maurizio
    Croce, Carlo M.
    Volinia, Stefano
    FRONTIERS IN GENETICS, 2018, 9
  • [49] PIK3CA and AKT1 Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System
    Beaver, Julia A.
    Gustin, John P.
    Yi, Kyung H.
    Rajpurohit, Anandita
    Thomas, Matthew
    Gilbert, Samuel F.
    Rosen, D. Marc
    Park, Ben Ho
    Lauring, Josh
    CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5413 - 5422
  • [50] An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development
    Shubham Upadhayay
    Narhari Gangaram Yedke
    Vikrant Rahi
    Surbhi Singh
    Sachin Kumar
    Anchal Arora
    Priyanka Chandolia
    Prabhsharan Kaur
    Mandeep Kumar
    Prashant Koshal
    Sumit Jamwal
    Puneet Kumar
    Neurochemical Research, 2023, 48 : 1631 - 1647
12345